Cargando…
WITHDRAWN: Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis presented as pulmonary-renal syndrome in a coronavirus disease-2019 (COVID-19) patient
Autores principales: | Apaydin, Hakan, Can Güven, Serdar, Doğan, İsmail, Çolak, Aysel, Süngü, Nuran, Erten, Şükran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463301/ http://dx.doi.org/10.1016/j.ejr.2021.08.011 |
Ejemplares similares
-
Antineutrophil cytoplasmic antibody positivity and clinical implications in COVID-19
por: Güven, Serdar Can, et al.
Publicado: (2022) -
Antineutrophil cytoplasmic antibodies (ANCA) – their role in pathogenesis, diagnosis, and treatment monitoring of ANCA-associated vasculitis
por: FIJOŁEK, JUSTYNA, et al.
Publicado: (2020) -
Subcutaneous Immunoglobulin for Antibody Deficiency in Antineutrophil Cytoplasmic Antibody (ANCA)-associated Vasculitis
por: Kant, Sam, et al.
Publicado: (2019) -
Tofacitinib-Induced Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis With Crescentic Glomerulonephritis
por: Asemota, Uyioghosa, et al.
Publicado: (2021) -
Suspicion Is Key: Diagnosing Elusive Cytoplasmic Antineutrophil Cytoplasmic Antibody (c-ANCA)-Positive Vasculitis
por: Crowe, Timothy P, et al.
Publicado: (2022)